Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 5th:
The E.W. Scripps Company (SSP - Free Report) : This media enterprise has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 15.3% over the last 60 days.
E.W. Scripps Company (The) Price and Consensus
E.W. Scripps’ shares gained 2.1% over the last one month more than S&P 500’s gain of 1.3%. The company possesses a Momentum Score of B.
E.W. Scripps Company (The) Price
Rexahn Pharmaceuticals, Inc. : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 9.5% over the last 60 days.
Rexahn Pharmaceuticals, Inc. Price and Consensus
Rexahn’s shares gained 9.3% over the last one month. The company possesses a Momentum Score of A.
Rexahn Pharmaceuticals, Inc. Price
Interface, Inc. (TILE - Free Report) : This modular flooring company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.
Interface, Inc. Price and Consensus
Interface’s shares gained 6.4% over the last one month. The company possesses a Momentum Score of B.
Interface, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 5th:
The E.W. Scripps Company (SSP - Free Report) : This media enterprise has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 15.3% over the last 60 days.
E.W. Scripps Company (The) Price and Consensus
E.W. Scripps’ shares gained 2.1% over the last one month more than S&P 500’s gain of 1.3%. The company possesses a Momentum Score of B.
E.W. Scripps Company (The) Price
Rexahn Pharmaceuticals, Inc. : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 9.5% over the last 60 days.
Rexahn Pharmaceuticals, Inc. Price and Consensus
Rexahn’s shares gained 9.3% over the last one month. The company possesses a Momentum Score of A.
Rexahn Pharmaceuticals, Inc. Price
Interface, Inc. (TILE - Free Report) : This modular flooring company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.
Interface, Inc. Price and Consensus
Interface’s shares gained 6.4% over the last one month. The company possesses a Momentum Score of B.
Interface, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on SSP - FREE
Get the latest research report on TILE - FREE